WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™, today announced that James Jenson, Ph.D., chief executive officer of Dicerna, will present at the Second Annual BIO National Venture Conference on March 31, 2009 at 2:40 p.m. (EDT) at the Sheraton Boston Hotel in Boston, Mass.
